A citation-based method for searching scientific literature

R Luthi-Carter, A Strand, N L Peters, S M Solano, Z R Hollingsworth, A S Menon, A S Frey, B S Spektor, E B Penney, G Schilling, C A Ross, D R Borchelt, S J Tapscott, A B Young, J H Cha, J M Olson. Hum Mol Genet 2000
Times Cited: 566







List of co-cited articles
1661 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Regional and cellular gene expression changes in human Huntington's disease brain.
Angela Hodges, Andrew D Strand, Aaron K Aragaki, Alexandre Kuhn, Thierry Sengstag, Gareth Hughes, Lyn A Elliston, Cathy Hartog, Darlene R Goldstein, Doris Thu,[...]. Hum Mol Genet 2006
530
44

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.
L Mangiarini, K Sathasivam, M Seller, B Cozens, A Harper, C Hetherington, M Lawton, Y Trottier, H Lehrach, S W Davies,[...]. Cell 1996
41

Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity.
F C Nucifora , M Sasaki, M F Peters, H Huang, J K Cooper, M Yamada, H Takahashi, S Tsuji, J Troncoso, V L Dawson,[...]. Science 2001
820
31

The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription.
J S Steffan, A Kazantsev, O Spasic-Boskovic, M Greenwald, Y Z Zhu, H Gohler, E E Wanker, G P Bates, D E Housman, L M Thompson. Proc Natl Acad Sci U S A 2000
789
28

Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.
M DiFiglia, E Sapp, K O Chase, S W Davies, G P Bates, J P Vonsattel, N Aronin. Science 1997
27

Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage.
Alexandre Kuhn, Darlene R Goldstein, Angela Hodges, Andrew D Strand, Thierry Sengstag, Charles Kooperberg, Kristina Becanovic, Mahmoud A Pouladi, Kirupa Sathasivam, Jang-Ho J Cha,[...]. Hum Mol Genet 2007
255
26

Neuropathological classification of Huntington's disease.
J P Vonsattel, R H Myers, T J Stevens, R J Ferrante, E D Bird, E P Richardson. J Neuropathol Exp Neurol 1985
25

Huntington disease.
J P Vonsattel, M DiFiglia. J Neuropathol Exp Neurol 1998
23

Integrated genomics and proteomics define huntingtin CAG length-dependent networks in mice.
Peter Langfelder, Jeffrey P Cantle, Doxa Chatzopoulou, Nan Wang, Fuying Gao, Ismael Al-Ramahi, Xiao-Hong Lu, Eliana Marisa Ramos, Karla El-Zein, Yining Zhao,[...]. Nat Neurosci 2016
192
23

Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes.
Chiara Zuccato, Marzia Tartari, Andrea Crotti, Donato Goffredo, Marta Valenza, Luciano Conti, Tiziana Cataudella, Blair R Leavitt, Michael R Hayden, Tõnis Timmusk,[...]. Nat Genet 2003
655
22

What have we learned from gene expression profiles in Huntington's disease?
Tamara Seredenina, Ruth Luthi-Carter. Neurobiol Dis 2012
99
21

Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease.
C Zuccato, A Ciammola, D Rigamonti, B R Leavitt, D Goffredo, L Conti, M E MacDonald, R M Friedlander, V Silani, M R Hayden,[...]. Science 2001
937
20

Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation.
S W Davies, M Turmaine, B A Cozens, M DiFiglia, A H Sharp, C A Ross, E Scherzinger, E E Wanker, L Mangiarini, G P Bates. Cell 1997
19

Molecular mechanisms and potential therapeutical targets in Huntington's disease.
Chiara Zuccato, Marta Valenza, Elena Cattaneo. Physiol Rev 2010
560
18

Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila.
J S Steffan, L Bodai, J Pallos, M Poelman, A McCampbell, B L Apostol, A Kazantsev, E Schmidt, Y Z Zhu, M Greenwald,[...]. Nature 2001
905
18

Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain.
Ruth Luthi-Carter, Sarah A Hanson, Andrew D Strand, Donald A Bergstrom, Wanjoo Chun, Nikki L Peters, Annette M Woods, Edmond Y Chan, Charles Kooperberg, Dimitri Krainc,[...]. Hum Mol Genet 2002
296
17

Role of brain-derived neurotrophic factor in Huntington's disease.
Chiara Zuccato, Elena Cattaneo. Prog Neurobiol 2007
386
17

Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease.
Anthone W Dunah, Hyunkyung Jeong, April Griffin, Yong-Man Kim, David G Standaert, Steven M Hersch, M Maral Mouradian, Anne B Young, Naoko Tanese, Dimitri Krainc. Science 2002
535
16

Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene.
J H Cha, C M Kosinski, J A Kerner, S A Alsdorf, L Mangiarini, S W Davies, J B Penney, G P Bates, A B Young. Proc Natl Acad Sci U S A 1998
412
16

Selective deficits in the expression of striatal-enriched mRNAs in Huntington's disease.
Paula A Desplats, Kristi E Kass, Tim Gilmartin, Gregg D Stanwood, Elliott L Woodward, Steven R Head, J Gregor Sutcliffe, Elizabeth A Thomas. J Neurochem 2006
105
16

Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice.
J A Bibb, Z Yan, P Svenningsson, G L Snyder, V A Pieribone, A Horiuchi, A C Nairn, A Messer, P Greengard. Proc Natl Acad Sci U S A 2000
236
16

Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease.
Elizabeth J Slow, Jeremy van Raamsdonk, Daniel Rogers, Sarah H Coleman, Rona K Graham, Yu Deng, Rosemary Oh, Nagat Bissada, Sazzad M Hossain, Yu-Zhou Yang,[...]. Hum Mol Genet 2003
587
16

Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats.
Liliana B Menalled, Jessica D Sison, Ioannis Dragatsis, Scott Zeitlin, Marie-Françoise Chesselet. J Comp Neurol 2003
337
15

Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington's disease: zQ175.
Liliana B Menalled, Andrea E Kudwa, Sam Miller, Jon Fitzpatrick, Judy Watson-Johnson, Nicole Keating, Melinda Ruiz, Richard Mushlin, William Alosio, Kristi McConnell,[...]. PLoS One 2012
235
15

Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin.
G Schilling, M W Becher, A H Sharp, H A Jinnah, K Duan, J A Kotzuk, H H Slunt, T Ratovitski, J K Cooper, N A Jenkins,[...]. Hum Mol Genet 1999
584
15

Huntington's disease: from molecular pathogenesis to clinical treatment.
Christopher A Ross, Sarah J Tabrizi. Lancet Neurol 2011
933
15


Differential loss of striatal projection neurons in Huntington disease.
A Reiner, R L Albin, K D Anderson, C J D'Amato, J B Penney, A B Young. Proc Natl Acad Sci U S A 1988
740
14


Histones associated with downregulated genes are hypo-acetylated in Huntington's disease models.
Ghazaleh Sadri-Vakili, Bérengère Bouzou, Caroline L Benn, Mee-Ohk Kim, Prianka Chawla, Ryan P Overland, Kelly E Glajch, Eva Xia, Zhihua Qiu, Steven M Hersch,[...]. Hum Mol Genet 2007
157
13

Extensive changes in DNA methylation are associated with expression of mutant huntingtin.
Christopher W Ng, Ferah Yildirim, Yoon Sing Yap, Simona Dalin, Bryan J Matthews, Patricio J Velez, Adam Labadorf, David E Housman, Ernest Fraenkel. Proc Natl Acad Sci U S A 2013
100
13

Targeting H3K4 trimethylation in Huntington disease.
Malini Vashishtha, Christopher W Ng, Ferah Yildirim, Theresa A Gipson, Ian H Kratter, Laszlo Bodai, Wan Song, Alice Lau, Adam Labadorf, Annie Vogel-Ciernia,[...]. Proc Natl Acad Sci U S A 2013
99
13

Huntington's disease.
Francis O Walker. Lancet 2007
13

Neurological abnormalities in a knock-in mouse model of Huntington's disease.
C H Lin, S Tallaksen-Greene, W M Chien, J A Cearley, W S Jackson, A B Crouse, S Ren, X J Li, R L Albin, P J Detloff. Hum Mol Genet 2001
444
13

Interaction of Huntington disease protein with transcriptional activator Sp1.
Shi-Hua Li, Anna L Cheng, Hui Zhou, Suzanne Lam, Manjula Rao, He Li, Xiao-Jiang Li. Mol Cell Biol 2002
258
12

Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington's disease knock-in mice.
Silvia Gines, Ihn Sik Seong, Elisa Fossale, Elena Ivanova, Flavia Trettel, James F Gusella, Vanessa C Wheeler, Francesca Persichetti, Marcy E MacDonald. Hum Mol Genet 2003
206
12

ESET/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington's disease.
Hoon Ryu, Junghee Lee, Sean W Hagerty, Byoung Yul Soh, Sara E McAlpin, Kerry A Cormier, Karen M Smith, Robert J Ferrante. Proc Natl Acad Sci U S A 2006
216
12

Genome-wide histone acetylation is altered in a transgenic mouse model of Huntington's disease.
Karen N McFarland, Sudeshna Das, Ting Ting Sun, Dmitri Leyfer, Eva Xia, Gavin R Sangrey, Alexandre Kuhn, Ruth Luthi-Carter, Timothy W Clark, Ghazaleh Sadri-Vakili,[...]. PLoS One 2012
59
20

Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease.
A Wyttenbach, J Swartz, H Kita, T Thykjaer, J Carmichael, J Bradley, R Brown, M Maxwell, A Schapira, T F Orntoft,[...]. Hum Mol Genet 2001
214
12

Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration.
Libin Cui, Hyunkyung Jeong, Fran Borovecki, Christopher N Parkhurst, Naoko Tanese, Dimitri Krainc. Cell 2006
757
12

Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice.
Michelle Gray, Dyna I Shirasaki, Carlos Cepeda, Véronique M André, Brian Wilburn, Xiao-Hong Lu, Jifang Tao, Irene Yamazaki, Shi-Hua Li, Yi E Sun,[...]. J Neurosci 2008
443
12

Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines.
Alexander V Panov, Claire-Anne Gutekunst, Blair R Leavitt, Michael R Hayden, James R Burke, Warren J Strittmatter, J Timothy Greenamyre. Nat Neurosci 2002
751
12

RNA Sequence Analysis of Human Huntington Disease Brain Reveals an Extensive Increase in Inflammatory and Developmental Gene Expression.
Adam Labadorf, Andrew G Hoss, Valentina Lagomarsino, Jeanne C Latourelle, Tiffany C Hadzi, Joli Bregu, Marcy E MacDonald, James F Gusella, Jiang-Fan Chen, Schahram Akbarian,[...]. PLoS One 2015
93
12

Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells.
F Trettel, D Rigamonti, P Hilditch-Maguire, V C Wheeler, A H Sharp, F Persichetti, E Cattaneo, M E MacDonald. Hum Mol Genet 2000
477
11

Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice.
Robert J Ferrante, James K Kubilus, Junghee Lee, Hoon Ryu, Ayshe Beesen, Birgit Zucker, Karen Smith, Neil W Kowall, Rajiv R Ratan, Ruth Luthi-Carter,[...]. J Neurosci 2003
490
11

Genomic landscape of transcriptional and epigenetic dysregulation in early onset polyglutamine disease.
Luis M Valor, Deisy Guiretti, Jose P Lopez-Atalaya, Angel Barco. J Neurosci 2013
48
22

Transcriptional abnormalities in Huntington disease.
Katharine L Sugars, David C Rubinsztein. Trends Genet 2003
421
11

Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington's disease.
Taneli Heikkinen, Kimmo Lehtimäki, Nina Vartiainen, Jukka Puoliväli, Susan J Hendricks, Jack R Glaser, Amyaouch Bradaia, Kristian Wadel, Chrystelle Touller, Outi Kontkanen,[...]. PLoS One 2012
148
11

A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration.
J G Hodgson, N Agopyan, C A Gutekunst, B R Leavitt, F LePiane, R Singaraja, D J Smith, N Bissada, K McCutcheon, J Nasir,[...]. Neuron 1999
635
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.